Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 22 entries
Sorted by: Best Match Show Resources per page
Massive parallel processing of image reconstruction from bispectrum through turbulence.

Applied optics

Hajmohammadi S, Nooshabadi S, Bos JP.
PMID: 26560760
Appl Opt. 2015 Nov 10;54(32):9370-8. doi: 10.1364/AO.54.009370.

This paper presents a massively parallel method for the phase reconstruction of an object from its bispectrum phase. Our aim is to recover an enhanced version of a turbulence-corrupted image by developing an efficient and fast parallel image-restoration algorithm....

Cite
Hajmohammadi S, Nooshabadi S, Bos JP. Massive parallel processing of image reconstruction from bispectrum through turbulence. Appl Opt. 2015;54(32):9370-8doi: 10.1364/AO.54.009370.
Hajmohammadi, S., Nooshabadi, S., & Bos, J. P. (2015). Massive parallel processing of image reconstruction from bispectrum through turbulence. Applied optics, 54(32), 9370-8. https://doi.org/10.1364/AO.54.009370
Hajmohammadi, Solmaz, et al. "Massive parallel processing of image reconstruction from bispectrum through turbulence." Applied optics vol. 54,32 (2015): 9370-8. doi: https://doi.org/10.1364/AO.54.009370
Hajmohammadi S, Nooshabadi S, Bos JP. Massive parallel processing of image reconstruction from bispectrum through turbulence. Appl Opt. 2015 Nov 10;54(32):9370-8. doi: 10.1364/AO.54.009370. PMID: 26560760.
Copy Download .nbib Format: NLM
Role of biomarkers in the management of antibiotic therapy: an expert panel review: I - currently available biomarkers for clinical use in acute infections.

Annals of intensive care

Dupuy AM, Philippart F, Péan Y, Lasocki S, Charles PE, Chalumeau M, Claessens YE, Quenot JP, Guen CG, Ruiz S, Luyt CE, Roche N, Stahl JP, Bedos JP, Pugin J, Gauzit R, Misset B, Brun-Buisson C.
PMID: 23837559
Ann Intensive Care. 2013 Jul 09;3(1):22. doi: 10.1186/2110-5820-3-22.

In the context of worldwide increasing antimicrobial resistance, good antimicrobial prescribing in more needed than ever; unfortunately, information available to clinicians often are insufficient to rely on. Biomarkers might provide help for decision-making and improve antibiotic management. The purpose...

Cite
Dupuy AM, Philippart F, Péan Y, et al. Role of biomarkers in the management of antibiotic therapy: an expert panel review: I - currently available biomarkers for clinical use in acute infections. Ann Intensive Care. 2013;3(1):22doi: 10.1186/2110-5820-3-22.
Dupuy, A. M., Philippart, F., Péan, Y., Lasocki, S., Charles, P. E., Chalumeau, M., Claessens, Y. E., Quenot, J. P., Guen, C. G., Ruiz, S., Luyt, C. E., Roche, N., Stahl, J. P., Bedos, J. P., Pugin, J., Gauzit, R., Misset, B., Brun-Buisson, C. (2013). Role of biomarkers in the management of antibiotic therapy: an expert panel review: I - currently available biomarkers for clinical use in acute infections. Annals of intensive care, 3(1), 22. https://doi.org/10.1186/2110-5820-3-22
Dupuy, Anne-Marie, et al. "Role of biomarkers in the management of antibiotic therapy: an expert panel review: I - currently available biomarkers for clinical use in acute infections." Annals of intensive care vol. 3,1 (2013): 22. doi: https://doi.org/10.1186/2110-5820-3-22
Dupuy AM, Philippart F, Péan Y, Lasocki S, Charles PE, Chalumeau M, Claessens YE, Quenot JP, Guen CG, Ruiz S, Luyt CE, Roche N, Stahl JP, Bedos JP, Pugin J, Gauzit R, Misset B, Brun-Buisson C. Role of biomarkers in the management of antibiotic therapy: an expert panel review: I - currently available biomarkers for clinical use in acute infections. Ann Intensive Care. 2013 Jul 09;3(1):22. doi: 10.1186/2110-5820-3-22. PMID: 23837559; PMCID: PMC3708786.
Copy Download .nbib Format: NLM
[No title available]

Frontiers in plant science

Bigard A, Berhe DT, Maoddi E, Sire Y, Boursiquot JM, Ojeda H, Péros JP, Doligez A, Romieu C, Torregrosa L.
PMID: 29765379
Front Plant Sci. 2018 May 01;9:455. doi: 10.3389/fpls.2018.00455. eCollection 2018.

The wine industry is facing critical issues due to climate changes since production is established on very tight Genotype × Environment interaction bases. While, some cultivation practices may reduce adverse effects of abiotic stresses on the vines, e.g., the...

Cite
Bigard A, Berhe DT, Maoddi E, et al. . Front Plant Sci. 2018;9:455doi: 10.3389/fpls.2018.00455.
Bigard, A., Berhe, D. T., Maoddi, E., Sire, Y., Boursiquot, J. M., Ojeda, H., Péros, J. P., Doligez, A., Romieu, C., & Torregrosa, L. (2018). . Frontiers in plant science, 9455. https://doi.org/10.3389/fpls.2018.00455
Bigard, Antoine, et al. "." Frontiers in plant science vol. 9 (2018): 455. doi: https://doi.org/10.3389/fpls.2018.00455
Bigard A, Berhe DT, Maoddi E, Sire Y, Boursiquot JM, Ojeda H, Péros JP, Doligez A, Romieu C, Torregrosa L. . Front Plant Sci. 2018 May 01;9:455. doi: 10.3389/fpls.2018.00455. eCollection 2018. PMID: 29765379; PMCID: PMC5938353.
Copy Download .nbib Format: NLM
Management and outcome of bloodstream infections: a prospective survey in 121 French hospitals (SPA-BACT survey).

Infection and drug resistance

Robineau O, Robert J, Rabaud C, Bedos JP, Varon E, Péan Y, Gauzit R, Alfandari S.
PMID: 30214256
Infect Drug Resist. 2018 Aug 31;11:1359-1368. doi: 10.2147/IDR.S165877. eCollection 2018.

BACKGROUND: Bloodstream infections (BSIs) are severe infections that can be community or hospital acquired. Effects of time to appropriate treatment and impact of antimicrobial management team are discussed in terms of outcome of BSI. We sought to evaluate the...

Cite
Robineau O, Robert J, Rabaud C, et al. Management and outcome of bloodstream infections: a prospective survey in 121 French hospitals (SPA-BACT survey). Infect Drug Resist. 2018;11:1359-1368doi: 10.2147/IDR.S165877.
Robineau, O., Robert, J., Rabaud, C., Bedos, J. P., Varon, E., Péan, Y., Gauzit, R., & Alfandari, S. (2018). Management and outcome of bloodstream infections: a prospective survey in 121 French hospitals (SPA-BACT survey). Infection and drug resistance, 111359-1368. https://doi.org/10.2147/IDR.S165877
Robineau, Oliver, et al. "Management and outcome of bloodstream infections: a prospective survey in 121 French hospitals (SPA-BACT survey)." Infection and drug resistance vol. 11 (2018): 1359-1368. doi: https://doi.org/10.2147/IDR.S165877
Robineau O, Robert J, Rabaud C, Bedos JP, Varon E, Péan Y, Gauzit R, Alfandari S. Management and outcome of bloodstream infections: a prospective survey in 121 French hospitals (SPA-BACT survey). Infect Drug Resist. 2018 Aug 31;11:1359-1368. doi: 10.2147/IDR.S165877. eCollection 2018. PMID: 30214256; PMCID: PMC6124465.
Copy Download .nbib Format: NLM
Differential piston phase variance in non-Kolmogorov atmospheres.

Journal of the Optical Society of America. A, Optics, image science, and vision

Bos JP, Rao Gudimetla VS, Schmidt JD.
PMID: 29036110
J Opt Soc Am A Opt Image Sci Vis. 2017 Aug 01;34(8):1433-1440. doi: 10.1364/JOSAA.34.001433.

We derive a generalized expression for the differential piston phase variance in non-Kolmogorov turbulence. Specifically, our result applies in the case where index of refraction is described by a power-law medium with an exponent between 0 and 1. Kolmogorov...

Cite
Bos JP, Rao Gudimetla VS, Schmidt JD. Differential piston phase variance in non-Kolmogorov atmospheres. J Opt Soc Am A Opt Image Sci Vis. 2017;34(8):1433-1440doi: 10.1364/JOSAA.34.001433.
Bos, J. P., Rao Gudimetla, V. S., & Schmidt, J. D. (2017). Differential piston phase variance in non-Kolmogorov atmospheres. Journal of the Optical Society of America. A, Optics, image science, and vision, 34(8), 1433-1440. https://doi.org/10.1364/JOSAA.34.001433
Bos, Jeremy P, et al. "Differential piston phase variance in non-Kolmogorov atmospheres." Journal of the Optical Society of America. A, Optics, image science, and vision vol. 34,8 (2017): 1433-1440. doi: https://doi.org/10.1364/JOSAA.34.001433
Bos JP, Rao Gudimetla VS, Schmidt JD. Differential piston phase variance in non-Kolmogorov atmospheres. J Opt Soc Am A Opt Image Sci Vis. 2017 Aug 01;34(8):1433-1440. doi: 10.1364/JOSAA.34.001433. PMID: 29036110.
Copy Download .nbib Format: NLM
Factors Associated With Treatment Failure in Moderately Severe Community-Acquired Pneumonia: A Secondary Analysis of a Randomized Clinical Trial.

JAMA network open

Dinh A, Duran C, Ropers J, Bouchand F, Davido B, Deconinck L, Matt M, Senard O, Lagrange A, Mellon G, Calin R, Makhloufi S, de Lastours V, Mathieu E, Kahn JE, Rouveix E, Grenet J, Dumoulin J, Chinet T, Pépin M, Delcey V, Diamantis S, Benhamou D, Vitrat V, Dombret MC, Guillemot D, Renaud B, Claessens YE, Labarère J, Aegerter P, Bedos JP, Crémieux AC.
PMID: 34652445
JAMA Netw Open. 2021 Oct 01;4(10):e2129566. doi: 10.1001/jamanetworkopen.2021.29566.

IMPORTANCE: Failure of treatment is the most serious complication in community-acquired pneumonia (CAP).OBJECTIVE: To assess the potential risk factors for treatment failure in clinically stable patients with CAP.DESIGN, SETTING, AND PARTICIPANTS: This secondary analysis assesses data from a randomized...

Cite
Dinh A, Duran C, Ropers J, et al. Factors Associated With Treatment Failure in Moderately Severe Community-Acquired Pneumonia: A Secondary Analysis of a Randomized Clinical Trial. JAMA Netw Open. 2021;4(10):e2129566doi: 10.1001/jamanetworkopen.2021.29566.
Dinh, A., Duran, C., Ropers, J., Bouchand, F., Davido, B., Deconinck, L., Matt, M., Senard, O., Lagrange, A., Mellon, G., Calin, R., Makhloufi, S., de Lastours, V., Mathieu, E., Kahn, J. E., Rouveix, E., Grenet, J., Dumoulin, J., Chinet, T., Pépin, M., Delcey, V., Diamantis, S., Benhamou, D., Vitrat, V., Dombret, M. C., Guillemot, D., Renaud, B., Claessens, Y. E., Labarère, J., Aegerter, P., Bedos, J. P., Crémieux, A. C. (2021). Factors Associated With Treatment Failure in Moderately Severe Community-Acquired Pneumonia: A Secondary Analysis of a Randomized Clinical Trial. JAMA network open, 4(10), e2129566. https://doi.org/10.1001/jamanetworkopen.2021.29566
Dinh, Aurélien, et al. "Factors Associated With Treatment Failure in Moderately Severe Community-Acquired Pneumonia: A Secondary Analysis of a Randomized Clinical Trial." JAMA network open vol. 4,10 (2021): e2129566. doi: https://doi.org/10.1001/jamanetworkopen.2021.29566
Dinh A, Duran C, Ropers J, Bouchand F, Davido B, Deconinck L, Matt M, Senard O, Lagrange A, Mellon G, Calin R, Makhloufi S, de Lastours V, Mathieu E, Kahn JE, Rouveix E, Grenet J, Dumoulin J, Chinet T, Pépin M, Delcey V, Diamantis S, Benhamou D, Vitrat V, Dombret MC, Guillemot D, Renaud B, Claessens YE, Labarère J, Aegerter P, Bedos JP, Crémieux AC. Factors Associated With Treatment Failure in Moderately Severe Community-Acquired Pneumonia: A Secondary Analysis of a Randomized Clinical Trial. JAMA Netw Open. 2021 Oct 01;4(10):e2129566. doi: 10.1001/jamanetworkopen.2021.29566. PMID: 34652445; PMCID: PMC8520128.
Copy Download .nbib Format: NLM
In vivo efficacy of cefotaxime and amoxicillin against penicillin-susceptible, penicillin-resistant and penicillin---cephalosporin-resistant strains of Streptococcus pneumoniae in a mouse pneumonia model.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases

Moine P, Sauve C, Vallee E, Bedos JP, Azoulay-Dupuis E.
PMID: 11864201
Clin Microbiol Infect. 1997 Feb;3(6):608-615. doi: 10.1111/j.1469-0691.1997.tb00466.x.

OBJECTIVE: To compare cefotaxime (CTX) to amoxicillin (AMO) (usually considered the definitive therapy for penicillin-susceptible Streptococcus pneumoniae infections) in an immunocompromised mouse pneumonia model. METHODS: Three S. pneumoniae clinical isolates were used: two serotype 19 strains, a penicillin-susceptible (Ps)...

Cite
Moine P, Sauve C, Vallee E, et al. In vivo efficacy of cefotaxime and amoxicillin against penicillin-susceptible, penicillin-resistant and penicillin---cephalosporin-resistant strains of Streptococcus pneumoniae in a mouse pneumonia model. Clin Microbiol Infect. 1997;3(6):608-615doi: 10.1111/j.1469-0691.1997.tb00466.x.
Moine, P., Sauve, C., Vallee, E., Bedos, J. P., & Azoulay-Dupuis, E. (1997). In vivo efficacy of cefotaxime and amoxicillin against penicillin-susceptible, penicillin-resistant and penicillin---cephalosporin-resistant strains of Streptococcus pneumoniae in a mouse pneumonia model. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 3(6), 608-615. https://doi.org/10.1111/j.1469-0691.1997.tb00466.x
Moine, Pierre, et al. "In vivo efficacy of cefotaxime and amoxicillin against penicillin-susceptible, penicillin-resistant and penicillin---cephalosporin-resistant strains of Streptococcus pneumoniae in a mouse pneumonia model." Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases vol. 3,6 (1997): 608-615. doi: https://doi.org/10.1111/j.1469-0691.1997.tb00466.x
Moine P, Sauve C, Vallee E, Bedos JP, Azoulay-Dupuis E. In vivo efficacy of cefotaxime and amoxicillin against penicillin-susceptible, penicillin-resistant and penicillin---cephalosporin-resistant strains of Streptococcus pneumoniae in a mouse pneumonia model. Clin Microbiol Infect. 1997 Feb;3(6):608-615. doi: 10.1111/j.1469-0691.1997.tb00466.x. PMID: 11864201.
Copy Download .nbib Format: NLM
Role of biomarkers in the management of antibiotic therapy: an expert panel review II: clinical use of biomarkers for initiation or discontinuation of antibiotic therapy.

Annals of intensive care

Quenot JP, Luyt CE, Roche N, Chalumeau M, Charles PE, Claessens YE, Lasocki S, Bedos JP, Péan Y, Philippart F, Ruiz S, Gras-Leguen C, Dupuy AM, Pugin J, Stahl JP, Misset B, Gauzit R, Brun-Buisson C.
PMID: 23830525
Ann Intensive Care. 2013 Jul 08;3(1):21. doi: 10.1186/2110-5820-3-21.

Biomarker-guided initiation of antibiotic therapy has been studied in four conditions: acute pancreatitis, lower respiratory tract infection (LRTI), meningitis, and sepsis in the ICU. In pancreatitis with suspected infected necrosis, initiating antibiotics best relies on fine-needle aspiration and demonstration...

Cite
Quenot JP, Luyt CE, Roche N, et al. Role of biomarkers in the management of antibiotic therapy: an expert panel review II: clinical use of biomarkers for initiation or discontinuation of antibiotic therapy. Ann Intensive Care. 2013;3(1):21doi: 10.1186/2110-5820-3-21.
Quenot, J. P., Luyt, C. E., Roche, N., Chalumeau, M., Charles, P. E., Claessens, Y. E., Lasocki, S., Bedos, J. P., Péan, Y., Philippart, F., Ruiz, S., Gras-Leguen, C., Dupuy, A. M., Pugin, J., Stahl, J. P., Misset, B., Gauzit, R., & Brun-Buisson, C. (2013). Role of biomarkers in the management of antibiotic therapy: an expert panel review II: clinical use of biomarkers for initiation or discontinuation of antibiotic therapy. Annals of intensive care, 3(1), 21. https://doi.org/10.1186/2110-5820-3-21
Quenot, Jean-Pierre, et al. "Role of biomarkers in the management of antibiotic therapy: an expert panel review II: clinical use of biomarkers for initiation or discontinuation of antibiotic therapy." Annals of intensive care vol. 3,1 (2013): 21. doi: https://doi.org/10.1186/2110-5820-3-21
Quenot JP, Luyt CE, Roche N, Chalumeau M, Charles PE, Claessens YE, Lasocki S, Bedos JP, Péan Y, Philippart F, Ruiz S, Gras-Leguen C, Dupuy AM, Pugin J, Stahl JP, Misset B, Gauzit R, Brun-Buisson C. Role of biomarkers in the management of antibiotic therapy: an expert panel review II: clinical use of biomarkers for initiation or discontinuation of antibiotic therapy. Ann Intensive Care. 2013 Jul 08;3(1):21. doi: 10.1186/2110-5820-3-21. PMID: 23830525; PMCID: PMC3716933.
Copy Download .nbib Format: NLM
Variation in Pathogenicity and Genetic Structure in the Eutypa lata Population of a Single Vineyard.

Phytopathology

Péros JP, Berger G, Lahogue F.
PMID: 18945047
Phytopathology. 1997 Aug;87(8):799-806. doi: 10.1094/PHYTO.1997.87.8.799.

ABSTRACT Fifty-five isolates of Eutypa lata were collected in 1994 from a single vineyard, each from a different vine that showed either shoot and foliar symptoms of Eutypa dieback or only abnormalities during the period of 1990 to 1994....

Cite
Péros JP, Berger G, Lahogue F. Variation in Pathogenicity and Genetic Structure in the Eutypa lata Population of a Single Vineyard. Phytopathology. 1997;87(8):799-806doi: 10.1094/PHYTO.1997.87.8.799.
Péros, J. P., Berger, G., & Lahogue, F. (1997). Variation in Pathogenicity and Genetic Structure in the Eutypa lata Population of a Single Vineyard. Phytopathology, 87(8), 799-806. https://doi.org/10.1094/PHYTO.1997.87.8.799
Péros, J P, et al. "Variation in Pathogenicity and Genetic Structure in the Eutypa lata Population of a Single Vineyard." Phytopathology vol. 87,8 (1997): 799-806. doi: https://doi.org/10.1094/PHYTO.1997.87.8.799
Péros JP, Berger G, Lahogue F. Variation in Pathogenicity and Genetic Structure in the Eutypa lata Population of a Single Vineyard. Phytopathology. 1997 Aug;87(8):799-806. doi: 10.1094/PHYTO.1997.87.8.799. PMID: 18945047.
Copy Download .nbib Format: NLM
Ilio-psoas hematoma in the intensive care unit: a multicentric study.

Annals of intensive care

Llitjos JF, Daviaud F, Grimaldi D, Legriel S, Georges JL, Guerot E, Bedos JP, Fagon JY, Charpentier J, Mira JP.
PMID: 26782681
Ann Intensive Care. 2016 Dec;6(1):8. doi: 10.1186/s13613-016-0106-z. Epub 2016 Jan 19.

BACKGROUND: Clinical features and outcomes of patients with spontaneous ilio-psoas hematoma (IPH) in intensive care units (ICUs) are poorly documented. The objectives of this study were to determine epidemiological, clinical, biological and management characteristics of ICU patients with IPH.METHODS:...

Cite
Llitjos JF, Daviaud F, Grimaldi D, et al. Ilio-psoas hematoma in the intensive care unit: a multicentric study. Ann Intensive Care. 2016;6(1):8doi: 10.1186/s13613-016-0106-z.
Llitjos, J. F., Daviaud, F., Grimaldi, D., Legriel, S., Georges, J. L., Guerot, E., Bedos, J. P., Fagon, J. Y., Charpentier, J., & Mira, J. P. (2016). Ilio-psoas hematoma in the intensive care unit: a multicentric study. Annals of intensive care, 6(1), 8. https://doi.org/10.1186/s13613-016-0106-z
Llitjos, J F, et al. "Ilio-psoas hematoma in the intensive care unit: a multicentric study." Annals of intensive care vol. 6,1 (2016): 8. doi: https://doi.org/10.1186/s13613-016-0106-z
Llitjos JF, Daviaud F, Grimaldi D, Legriel S, Georges JL, Guerot E, Bedos JP, Fagon JY, Charpentier J, Mira JP. Ilio-psoas hematoma in the intensive care unit: a multicentric study. Ann Intensive Care. 2016 Dec;6(1):8. doi: 10.1186/s13613-016-0106-z. Epub 2016 Jan 19. PMID: 26782681; PMCID: PMC4717128.
Copy Download .nbib Format: NLM
The alkaloid centcyamine increases expression of klotho and lamin B1, slowing the onset of skin ageing in vitro and in vivo.

International journal of cosmetic science

Abadie S, Leduc C, Lintner K, Bedos P.
PMID: 34403147
Int J Cosmet Sci. 2021 Oct;43(5):561-572. doi: 10.1111/ics.12731. Epub 2021 Sep 13.

BACKGROUND: Klotho is a protein known for its beneficial effects on longevity. Centcyamine is an alkaloid present in certain plants whose extracts have an anti-inflammatory effect. Skin fibroblasts are essential to the formation and structure of the dermis.OBJECTIVE: Centcyamine...

Cite
Abadie S, Leduc C, Lintner K, et al. The alkaloid centcyamine increases expression of klotho and lamin B1, slowing the onset of skin ageing in vitro and in vivo. Int J Cosmet Sci. 2021;43(5):561-572doi: 10.1111/ics.12731.
Abadie, S., Leduc, C., Lintner, K., & Bedos, P. (2021). The alkaloid centcyamine increases expression of klotho and lamin B1, slowing the onset of skin ageing in vitro and in vivo. International journal of cosmetic science, 43(5), 561-572. https://doi.org/10.1111/ics.12731
Abadie, Sophie, et al. "The alkaloid centcyamine increases expression of klotho and lamin B1, slowing the onset of skin ageing in vitro and in vivo." International journal of cosmetic science vol. 43,5 (2021): 561-572. doi: https://doi.org/10.1111/ics.12731
Abadie S, Leduc C, Lintner K, Bedos P. The alkaloid centcyamine increases expression of klotho and lamin B1, slowing the onset of skin ageing in vitro and in vivo. Int J Cosmet Sci. 2021 Oct;43(5):561-572. doi: 10.1111/ics.12731. Epub 2021 Sep 13. PMID: 34403147.
Copy Download .nbib Format: NLM
Comparison of prognostic factors between bacteraemic and non-bacteraemic critically ill immunocompetent patients in community-acquired severe pneumococcal pneumonia: a STREPTOGENE sub-study.

Annals of intensive care

Bellut H, Porcher R, Varon E, Asfar P, Le Tulzo Y, Megarbane B, Mathonnet A, Dugard A, Veinstein A, Ouchenir K, Siami S, Reignier J, Galbois A, Cousson J, Preau S, Baldesi O, Rigaud JP, Souweine B, Misset B, Jacobs F, Dewavrin F, Mira JP, Bedos JP.
PMID: 34689255
Ann Intensive Care. 2021 Oct 24;11(1):148. doi: 10.1186/s13613-021-00936-z.

BACKGROUND: The presence of bacteraemia in pneumococcal pneumonia in critically ill patients does not appear to be a strong independent prognostic factor in the existing literature. However, there may be a specific pattern of factors associated with mortality for...

Cite
Bellut H, Porcher R, Varon E, et al. Comparison of prognostic factors between bacteraemic and non-bacteraemic critically ill immunocompetent patients in community-acquired severe pneumococcal pneumonia: a STREPTOGENE sub-study. Ann Intensive Care. 2021;11(1):148doi: 10.1186/s13613-021-00936-z.
Bellut, H., Porcher, R., Varon, E., Asfar, P., Le Tulzo, Y., Megarbane, B., Mathonnet, A., Dugard, A., Veinstein, A., Ouchenir, K., Siami, S., Reignier, J., Galbois, A., Cousson, J., Preau, S., Baldesi, O., Rigaud, J. P., Souweine, B., Misset, B., Jacobs, F., Dewavrin, F., Mira, J. P., & Bedos, J. P. (2021). Comparison of prognostic factors between bacteraemic and non-bacteraemic critically ill immunocompetent patients in community-acquired severe pneumococcal pneumonia: a STREPTOGENE sub-study. Annals of intensive care, 11(1), 148. https://doi.org/10.1186/s13613-021-00936-z
Bellut, Hugo, et al. "Comparison of prognostic factors between bacteraemic and non-bacteraemic critically ill immunocompetent patients in community-acquired severe pneumococcal pneumonia: a STREPTOGENE sub-study." Annals of intensive care vol. 11,1 (2021): 148. doi: https://doi.org/10.1186/s13613-021-00936-z
Bellut H, Porcher R, Varon E, Asfar P, Le Tulzo Y, Megarbane B, Mathonnet A, Dugard A, Veinstein A, Ouchenir K, Siami S, Reignier J, Galbois A, Cousson J, Preau S, Baldesi O, Rigaud JP, Souweine B, Misset B, Jacobs F, Dewavrin F, Mira JP, Bedos JP. Comparison of prognostic factors between bacteraemic and non-bacteraemic critically ill immunocompetent patients in community-acquired severe pneumococcal pneumonia: a STREPTOGENE sub-study. Ann Intensive Care. 2021 Oct 24;11(1):148. doi: 10.1186/s13613-021-00936-z. PMID: 34689255; PMCID: PMC8542522.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 22 entries